Explore the latest developments concerning Legislators object to.
Legislators object to proposed CMS payment changes for diabetes tech
Let MedTech Dive's free newsletter keep you informed, straight from your inbox.
In a letter to CMS Administrator Mehmet Oz, diabetes caucus leaders raised concerns that the agency’s proposals will reduce access to glucose monitors and insulin pumps.
This summer, diabetes tech companies, including insulin-pump makers Tandem Diabetes Care and Insulet, said they were watching the CMS proposal. At the time, they did not forecast much of an impact on their businesses.
In their letter, Sens. Jeanne Shaheen, D-N.H., and Susan Collins, R-Maine, and Reps. Diana DeGette, D-Colo., and Gus Bilirakis, R-Fla., raised concerns that a few suppliers would be responsible for furnishing durable insulin pumps and CGMs to beneficiaries if the proposal were made final. These suppliers would also be responsible for maintenance, software updates and recalls. Currently, manufacturers are responsible for support.
GOP Senator Urges Dr. Oz to Rescind Proposal, "We Are Concerned"
2paragraphs publishes news on entertainment, politics, TV, sports, culture, celebrity, fashion, and trends. 2paragraphs’ original reporting brings accuracy, depth and context to what's happening. 2paragraphs is an independent, trusted news source.
As the co-chairs of the House and Senate Diabetes Caucuses, U.S. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH) and U.S. Representatives Diana DeGette (D-CO) and Gus Bilirakis (R-FL) sent a letter to President Trump’s Administrator for the Centers for Medicare & Medicaid Services, Mehmet Oz (a.k.a. Dr. Oz), urging him to rescind a proposal.
According to the bipartisan caucus leadership, the proposal for CMS’s Medicare Competitive Bidding Program “would make it harder for diabetic patients to access lifesaving tools like glucose monitors and insulin pumps.”
13×4 13×6 360 HD Transparent 613 Lace Frontal Wig Honey Blonde Color Brazilian Raw Body Wave Lace Front Human Hair Wig for Women
Press Release: Senators Shaheen and Collins, Representatives DeGette and Bilirakis Urge CMS to Reconsider Proposal Affecting Diabetic Patient Access to Glucose Monitors and Insulin Pumps
Unlock the investing wisdom of Congress,
Wall Street, and thousands of other insiders
Be the first to see our newest insights and key updates across all datasets
Build and test your own strategies, using Quiver's Congressional trading datasets
Build and test your own strategies, using Quiver's Institutional holdings datasets
Our video reports and analysis, with early access to exclusive, subscriber-only videos
Sens. Shaheen and Collins, along with Reps. DeGette and Bilirakis, oppose CMS proposal limiting diabetic patient access to essential devices.
Lawmakers express concern over CMS proposal: Senators Jeanne Shaheen and Susan Collins, along with Representatives Diana DeGette and Gus Bilirakis, have warned the Centers for Medicare & Medicaid Services (CMS) against a proposed rule that could restrict access to continuous glucose monitors and insulin pumps for diabetic patients. They argue it may limit suppliers and increase barriers for patients.